KINSHASA (Reuters) - The Democratic Republic of Congo announced on Thursday the first confirmed death in a new outbreak of Ebola virus and said 11 other people were now confirmed to be infected, including three medical staff.
(Reuters) - Britain's Wellcome Trust global health charity called for a rapid response to an outbreak of Ebola in the Democratic Republic of Congo (DRC) and has pledged 2 million pounds ($2.7 mln)to support Kinshasa's efforts to fight it.
WASHINGTON (Reuters) - As U.S. President Donald Trump prepares to deliver a long-anticipated speech on Friday on curbing prescription drug costs, health industry insiders expect little in the way of policies that would hurt the drugmakers he once accused of "getting away with murder."
(Reuters) - Pharmaceuticals company Mylan NV said on Thursday that one of its subsidiary received a civil investigative demand from the U.S. Department of Justice regarding its compliance with the Trades Agreement Act (TAA) for certain products, according to a filing with the U.S. Securities and Exchange Commission.
LONDON (Reuters) - AstraZeneca's said its first respiratory biologic medicine Fasenra failed to meet its target in a clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD).
BASEL (Reuters) - A 104-year-old Australian scientist killed himself in Switzerland on Thursday by lethal injection in an assisted suicide he hoped would trigger more lenient euthanasia laws in his home country.
ZURICH (Reuters) - Roche's hopes of its Tecentriq immunotherapy catching rival medicines from Merck and Bristol-Myers Squibb were dealt a blow on Thursday after it failed a key combination trial.
NENAGH/CORK, Ireland (Reuters) - Three decades after Ireland introduced one of the world's only constitutional bans on abortion, the Church that was so pivotal in securing the law's passage finds itself a minor player in the now mainly secular battle to repeal it.
(Reuters) - Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to expand its portfolio of drugs that helps body's immune system fight cancer as the U.S. drugmaker chases rivals in a lucrative market.
LONDON (Reuters) - European makers of emergency allergy treatments are stepping up production of alternative life-saving adrenaline shots to try to fill intermittent shortages of Mylan's market-leading EpiPen injection.
Scientists train a species of predatory spider to leap on demand in a bid to better understand how they catch their prey and potentially inspire new micro-robots. Matthew Stock reports.
A team of engineers searching for sustainable alternatives to carbon fibre say recyclable car parts made with natural fibres are a realistic possibility. Stuart McDill reports.
You might like...
Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.
